| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Platform: GPL19057
|
Mus musculus
|
Jul 23, 2024
|
|||||
| GSE246984 |
The impact of the embryonic DNA methylation program on CTCF-mediated genome regulation
|
|
28 | Julien Richard Albert | Jul 23, 2024 | |||
| GSE248933 |
Transcriptomic and epigenomic profiling of Tet TKO neural stem cells to study NSC specification and multipotency
|
|
36 | Meelad M Dawlaty | Jul 23, 2024 | |||
| GSE160519 |
Vascular and perivascular cell profiling reveals the molecular and cellular bases of blood-brain barrier heterogeneity [scRNA-Seq]
|
|
52 | Sarah Pfau | Jul 23, 2024 | |||
| GSE222941 |
Endomucin marks quiescent long-term multi-lineage repopulating hematopoietic stem cells and is essential for their transendothelial migration [RNA-seq: wildtype_EMCN]
|
|
11 | Kim Theilgaard-Mönch | Jul 23, 2024 | |||
| GSE222942 |
Endomucin marks quiescent long-term multi-lineage repopulating hematopoietic stem cells and is essential for their transendothelial migration [RNA-seq: EMCN_KO]
|
|
7 | Kim Theilgaard-Mönch | Jul 23, 2024 | |||
| GSE241206 |
Vascular and perivascular cell profiling reveals the molecular and cellular bases of blood-brain barrier heterogeneity
|
|
105 | Sarah Pfau | Jul 23, 2024 | |||
| GSE189812 |
Engineered T cell therapy for central nervous system injury [control tissues TCR scRNA-seq]
|
|
8 | Jonathan Kipnis | Jul 23, 2024 | |||
| GSE216390 |
Engineered T cell therapy for central nervous system injury [spinal cord TCR scRNA-seq]
|
|
4 | Jonathan Kipnis | Jul 23, 2024 | |||
| GSE216391 |
Engineered T cell therapy for central nervous system injury
|
|
230 | Jonathan Kipnis | Jul 23, 2024 | |||
| GSE222943 |
Endomucin marks quiescent long-term multi-lineage repopulating hematopoietic stem cells and is essential for their transendothelial migration
|
|
18 | Kim Theilgaard-Mönch | Jul 23, 2024 |
